Skip to main content

Closed

BOLD: Boundless Bio, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-45.1%

Financially safe

Stretched

Debt / equity0.56×

Interest coverage0.0×

Current ratio9.87×

Boundless Bio, Inc.

BOLDNASDAQ Global Select·USD·Closed

Boundless Bio, Inc.

BOLDNASDAQ·USD·Closed

$2.50

+0.00%

$2.50

+$0.00 (0.00%)

52W Range

84thpctl

Volume

0.08×avg

Mkt Cap

56.19MUSD

P/E

-1.0TTM

Div Yield

–ann

52W Range

84thpctl

Volume

0.08×avg

Market Cap

56.19MUSD

P/E Ratio

-1.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings